On Wednesday, Shares of Gilead Sciences, Inc. (NASDAQ:GILD), subtract -0.46% and closed at $76.00 in the last trading session. The last trading range of the stock ranges between $75.57 and $76.88. Gilead Sciences, Inc. (Overlay) as of late proclaimed the advancement of James R. Meyers to Executive Vice President, Worldwide Commercial Operations, with duty regarding business operations in North America, Europe and Japan. Mr. Meyers will turn into an officer of the organization and individual from Gilead’s senior initiative group.
Mr. Meyers joined Gilead in 1996 as a territorial deals executive and has been the Senior Vice President of North American Commercial Operations since 2007. In his 20 years at Gilead, Mr. Meyers has been instrumental in working out the organization’s business operations in North America, including driving effective item dispatches HIV, oncology, cardiovascular, respiratory and liver illnesses. Before Gilead, Mr. Meyers held places of expanding duty in deals, preparing, advertising and organization with Zeneca Pharmaceuticals and Astra USA. He got his Bachelor’s degree in financial aspects from Boston College.
“Jim has shown an exceptional capacity to explore the complexities of business operations, guaranteeing we contact different groups of onlookers with data about Gilead’s medications and inevitably that we make those drugs open to individuals in need,” said Kevin Young CBE, Chief Operating Officer, Gilead Sciences. “I am sure that as Gilead’s arrangement of items keeps on developing, Jim’s administration and extraordinary reputation make him in a perfect world suited to lead our worldwide business association.”
Gevo, Inc. (NASDAQ:GEVO), Dropped -2.88% and closed at $0.341 in the last trading session. The last trading range of the stock ranges between $0.34 and $0.36. The company’s Market capitalization is $41.85 Million with the total Outstanding Shares of 136.45 Million. Gevo, Inc. (GEVO) recently declared financial results for the three months ended September 30, 2016. Key highlights for the quarter included:
Gevo produced about 145,000 gallons of isobutanol during the quarter.
On November 14, Alaska Airline flew the first commercial flight with Gevo’s cellulosic Alcohol-to-Jet fuel (“ATJ”). Formerly, on October 11, 2016, Gevo declared that it had accomplished production of the world’s first cellulosic renewable jet fuel that is specified for commercial flights. Gevo successfully adapted its patented technologies to convert cellulosic sugars derived from wood waste into renewable isobutanol, which was then further converted into its ATJ. This ATJ meets the ASTM D7566 specification allowing it to be used for commercial flights. Gevo produced over 1,000 gallons of the cellulosic ATJ.
On November 10, Gevo declared that gasoline blended with its isobutanol and marketed for use in automobiles has begun to be sold in the Houston area. This marks the first time that Gevo’s isobutanol has been specifically targeted towards on-road vehicles. Musket Corporation is Gevo’s distribution partner serving the Houston market. Musket is blending up specially formulated gasoline containing Gevo’s isobutanol to distribute into the on-road automobile market.